Gaarnis Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 29-12-2024
- Paid Up Capital ₹ 1.00 M
as on 29-12-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.50 M
as on 29-12-2024
- Revenue 154.94%
(FY 2022)
- Profit 94.46%
(FY 2022)
- Ebitda 108.39%
(FY 2022)
- Net Worth -16.76%
(FY 2022)
- Total Assets 12.08%
(FY 2022)
About Gaarnis Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹0.50 M.
Amalsabu Kalakal and Preethi Santhamma serve as directors at the Company.
- CIN/LLPIN
U24230KL2016PTC040342
- Company No.
040342
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Mar 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Gaarnis Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amalsabu Kalakal  | Director | 11-Mar-2016 | Current |
| Preethi Santhamma | Director | 01-Mar-2024 | Current |
Financial Performance of Gaarnis Pharma.
Gaarnis Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 154.94% increase. The company also saw a substantial improvement in profitability, with a 94.46% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gaarnis Pharma?
In 2022, Gaarnis Pharma had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 17 Dec 2016 | ₹0.50 M | Open |
How Many Employees Work at Gaarnis Pharma?
Gaarnis Pharma has a workforce of 4 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gaarnis Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gaarnis Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
